| We actively represent patient interests before healthcare regulators and the National Health Basket Committee of Israel. | Respiratory
> Asthma and COPD | Regulatory partnership
> Working with regulatory bodies | We do not communicate with patients directly | National | Regularly | 119068242117 |
| We actively represent patient interests before healthcare regulators and the National Health Basket Committee of Israel. | Respiratory
> Asthma and COPD | Regulatory partnership
> Participate in Health Technology Assessment (HTA) and reimbursement reviews | We do not communicate with patients directly | National | Regularly | 119068242117 |
| We have influence over the drugs included in the basket of medicines that receive regulatory pricing. This is an annual process to which we are able to contribute. | Autoimmune
> Autoimmune: most types | Regulatory partnership
> Participate in Health Technology Assessment (HTA) and reimbursement reviews | 5,000 | National | Sometimes | 119068245670 |
| We are applying to the Health office about including IVIG [Intravenous Immunoglobulin] as an indication to treat Myasthenia Gravis. | Neuromuscular
> Myasthenia gravis | Regulatory partnership
> Participate in Health Technology Assessment (HTA) and reimbursement reviews | 1,000 | National | Sometimes | 119074555668 |
| Raising awareness for drug technologies, helping new drugs to be approved by government, etc. | Patient advocacy
> Drugs and related treatments | Regulatory partnership
> Contribute to Marketing Authorisation submissions | 5,000 | National | Regularly | 119062572474 |
| Once a year, we submit our support to the National Health Basket Committee of Israel. We talk regularly with the regulators, but not on drug pricing. | Transplants
> Transplants: heart and lung | Regulatory partnership
> Attend/facilitate meetings with policymakers/regulators | 100,000 | National | Rarely | 119058027478 |
| ... We talk regularly with the regulators, but not on drug pricing. | Transplants
> Transplants: heart and lung | Regulatory partnership
> Attend/facilitate meetings with policymakers/regulators | 100,000 | National | Rarely | 119058027478 |
| Changing laws. | General health
> Sexual health: other | Impacting policy and legislation
> Influence healthcare policy and legislation | 5,000 | National | Regularly | 119020325100 |
| Our organisation raises patient needs related to access to treatments and affordability through collaborations, policy discussions, and engagement with stakeholders in the healthcare system. | Patient advocacy
> Patient advocacy | Impacting policy and legislation
> Influence healthcare policy and legislation | 10,000 | National | Sometimes | 119084033692 |
| In government committees, in submitting position papers, etc. | Patient advocacy
> Drugs and related treatments | Impacting policy and legislation
> Participate in public hearings and consultations | 5,000 | National | Sometimes | 119025692602 |
| We are applying to the Health office about including IVIG [Intravenous Immunoglobulin] as an indication to treat Myasthenia Gravis. | Neuromuscular
> Myasthenia gravis | Impacting policy and legislation
> Addressing barriers/anomalies in medical care | 1,000 | National | Sometimes | 119074555668 |
| An attempt to lower the price of a certain drug so that it will be included in the public drug basket in Israel. | Cancer
> Cancer: prostate | Pricing and affordability advocacy
> Advocate for fair medicine pricing | 10,000 | National | Rarely | 119065366296 |
| We actively represent patient interests before healthcare regulators and the National Health Basket Committee. We advocate for the inclusion of essential treatments and medications in the national reimbursement list, ensuring that patient needs are prioritised in pricing and accessibility decisions. | Respiratory
> Asthma and COPD | Pricing and affordability advocacy
> Advocate for fair medicine pricing | We do not communicate with patients directly | National | Regularly | 119068242117 |
| Our organisation raises patient needs related to access to treatments and affordability through collaborations, policy discussions, and engagement with stakeholders in the healthcare system. | Patient advocacy
> Patient advocacy | Pricing and affordability advocacy
> Advocate for fair medicine pricing | 10,000 | National | Sometimes | 119084033692 |
| We have influence over the drugs included in the basket of medicines that receive regulatory pricing. This is an annual process to which we are able to contribute. | Autoimmune
> Autoimmune: most types | Pricing and affordability advocacy
> Engage in price-review board negotiations | 5,000 | National | Sometimes | 119068245670 |
| An attempt to lower the price of a certain drug so that it will be included in the public drug basket in Israel. | Cancer
> Cancer: prostate | Pricing and affordability advocacy
> Advocating for inclusion of product in reimbursement lists/national formularies | 10,000 | National | Rarely | 119065366296 |
| We advocate for the inclusion of essential treatments and medications in the national reimbursement list, ensuring that patient needs are prioritised in pricing and accessibility decisions. | Respiratory
> Asthma and COPD | Pricing and affordability advocacy
> Advocating for inclusion of product in reimbursement lists/national formularies | We do not communicate with patients directly | National | Regularly | 119068242117 |
| Our organisation raises patient needs, related to access to treatments and affordability through collaborations, policy discussions, and engagement with stakeholders in the healthcare system. | Patient advocacy
> Patient advocacy | Improving access pathways
> Facilitate equitable access to medicines/healthcare | 10,000 | National | Sometimes | 119084033692 |
| In government committees, in submitting position papers, etc. | Patient advocacy
> Drugs and related treatments | Institutional governance
> Ensure representation within governmental advisory bodies | 5,000 | National | Sometimes | 119025692602 |
| We actively represent patient interests before healthcare regulators and the National Health Basket Committee of Israel. | Respiratory
> Asthma and COPD | Institutional governance
> Ensure representation within governmental advisory bodies | We do not communicate with patients directly | National | Regularly | 119068242117 |
| Workplaces that do not give the patient permission to see the doctor at the right time. | General health
> Sexual health: other | Upholding patient rights/improving quality of life
> Protecting/improving the patient experience | 5,000 | National | Regularly | 119035841801 |
interactions
actions & advocacy
6 mentions
